The #1 genetic killer of children in Africa is Sickle Cell Anemia. Children with Sickle Cell live in severe pain and 75% of them die by the age of 5. There is no effective treatment for sickle cell, so we have tried to support these children through a variety of nutritional supplements and saw only marginal results. Then we conducted a quality-of-life impact pilot on Sickle Cell children using MannaRelief’s new advanced immune optimizing Acemannan product. We were shocked at the results. Over 80% of the children showed significant improvement in their most critical symptoms. The government of Nigeria was so impressed with these results that it approved a multi-site study to evaluate this new Acemannan’s quality-of-life impact on Sickle Cell children.

Dr. David Ajibade, Founder and Medical Director of Brain and Body Foundation